Vitamin E Supplementation Delays Cellular Senescence In Vitro

Area of Science:

• Cell Biology
• Biochemistry
• Gerontology

Background:

• Cellular senescence is a hallmark of aging, characterized by irreversible growth arrest and linked to oxidative stress.
• Senescence-associated β-galactosidase (SA-β-gal) is a widely used biomarker for identifying senescent cells.
• Vitamin E, a potent antioxidant, is investigated for its potential role in mitigating age-related cellular damage.

Purpose of the Study:

• To investigate the effects of vitamin E supplementation on cellular senescence in human primary cells (HUVECs and fibroblasts).
• To explore the potential anti-aging properties of vitamin E in vitro.
• To elucidate the molecular mechanisms underlying vitamin E's impact on senescence.

Main Methods:

• Utilized an automated system for quantifying senescence based on SA-β-gal expression.
• Supplemented human umbilical vein endothelial cells (HUVECs) and fibroblasts with vitamin E.
• Assessed cellular proliferation and P21 gene expression following vitamin E treatment.

Main Results:

• Vitamin E supplementation significantly reduced the number of senescent cells in both HUVECs and fibroblasts.
• Acute vitamin E treatment did not impact cellular proliferation, but chronic treatment led to decreased proliferation.
• Vitamin E's mechanism involves the downregulation of the cyclin-dependent kinase inhibitor P21 expression.

Conclusions:

• Vitamin E exhibits anti-aging properties by reducing cellular senescence.
• The study identifies P21 downregulation as a key mechanism for vitamin E's anti-senescence effects.
• Further research is warranted to explore vitamin E's therapeutic potential in aging.